当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

抽象的な

Mucosal Inflammation Immunology

Dr. Omar Shattuck

Immunotherapy has revolutionized the landscape of cancer treatment, offering new hope and opportunities for patients battling various types of cancer. Unlike traditional treatment modalities such as surgery, chemotherapy, and radiation therapy, which directly target cancer cells, immunotherapy works by stimulating the body's immune system to recognize and attack cancer cells. This article explores the concept of immunotherapy, its mechanisms, different approaches, and its remarkable impact on cancer treatment. Immunotherapy has emerged as a groundbreaking approach in cancer treatment, offering new avenues for patients battling various malignancies. Unlike traditional therapies that directly target cancer cells, immunotherapy harnesses the power of the immune system to recognize and eliminate cancer cells. This abstract provides a concise overview of the principles, mechanisms, and clinical impact of immunotherapy. Immunotherapy utilizes different strategies to enhance the immune response against cancer. Checkpoint inhibitors, such as PD-1 and CTLA-4 inhibitors, release the brakes on the immune system, enabling it to effectively recognize and destroy cancer cells. CAR-T cell therapy genetically modifies a patient's T cells to target specific cancer cells, while immune-modulating antibodies directly target cancer cells or stimulate immune responses. Cancer vaccines and adoptive cell transfer further bolster the immune system's ability to combat cancer.The impact of immunotherapy in cancer treatment has been remarkable. It has revolutionized the management of various malignancies, leading to durable responses and long-term remission in patients. Immunotherapy has shown particular success in metastatic melanoma, lung cancer, and kidney cancer. Ongoing research aims to expand the application of immunotherapy to other cancer types and improve treatment outcomes.